Camlin Fine Sciences Limited (CAMLINFINE)

Chemicals · Chemicals & Petrochemicals · NSE · Updated 20 July 2026

₹122.69 ↓ 61.47% (1Y)

🎯 Key Takeaways

Camlin Fine Sciences Limited is in a strategic transition phase, shifting from a legacy commodity chemicals business toward high-growth specialty ingredients and natural products, driven by acquisitions like Vinpai and management's focus on value-added segments. Despite revenue growth, persistent losses and margin compression indicate the company is still in an investment phase with a long path to profitability.
Revenue grew 2.5% QoQ to ₹433 in Q3FY25.
⚠️ 1) Persistent margin pressure from rising input costs, currency volatility, and geopolitical disruptions affecting raw material supply and pricing. 2)

Market Cap

₹2,408

P/E Ratio

-9.7

Div Yield

0.00%

Promoter

0.0%

✨ Ask AI About CAMLINFINE 📊 Interactive Charts

📖 The Story

Camlin Fine Sciences Limited is in a strategic transition phase, shifting from a legacy commodity chemicals business toward high-growth specialty ingredients and natural products, driven by acquisitions like Vinpai and management's focus on value-added segments. Despite revenue growth, persistent losses and margin compression indicate the company is still in an investment phase with a long path to profitability.

📰 What's Happening

In Q4 FY26, the company reported consolidated revenue of ₹32,618.86 lakh with a net loss of Rs. (350.27) lakh, reflecting ongoing margin pressures from rising input costs, currency volatility, and geopolitical headwinds. Management highlighted progress in specialty ingredients and blends, with blended revenue reaching ₹569 million in FY26, and emphasized strategic growth through acquisitions such as Vinpai to expand in natural ingredients and improve vanillin realizations post-US tariff withdrawal. The board remains focused on operational improvements amid challenging macro conditions, with no dividend declared since FY16-17.

Source: Stock Announcements

📊 Quarterly Results (₹ Cr)

Metric	Q4FY23	Q1FY24	Q2FY24	Q3FY24	Q4FY24	Q1FY25	Q2FY25	Q3FY25
Revenue	427	420	406	386	402	396	423	433
Operating Profit	36	45	27	25	-57	20	-96	50
OPM %	10.3%	9.2%	6.2%	6.0%	-3.3%	4.6%	10.2%	11.3%
Net Profit	3	12	-21	-14	-82	-35	-116	-7
EPS	₹0.59	₹0.96	₹-1.17	₹-0.71	₹-4.64	₹-2.03	₹-5.98	₹-0.24

Revenue has shown modest YoY growth, rising to ₹17,233 crores in FY26 from ₹16,287 crores in FY25, but profitability remains under strain, with adjusted EBITDA margin declining to 5.0% in Q4 FY26 from 6.8% in the prior quarter due to higher finance costs and exceptional items. Quarterly operating performance has been volatile, swinging from a ₹12 crore profit in Q1 FY24 to a ₹116 crore loss in Q2 FY25, indicating inconsistent execution amid input cost inflation and foreign exchange pressures. The company is investing in capacity expansion and strategic acquisitions, but near-term profitability is being sacrificed for market positioning in high-growth segments.

🔮 Management Outlook & What's Next

Management expressed confidence in long-term growth through its specialty ingredients and natural products strategy, citing improved vanillin realizations following the withdrawal of US tariffs on key inputs. The company is actively pursuing inorganic growth, as evidenced by its acquisition of Vinpai and the subsequent tender offer to fully consolidate ownership. However, no specific financial targets or timelines for margin recovery or profitability were provided in the latest disclosures, with management focusing on operational resilience amid external headwinds.

Extracted from official company announcements. Not StockFin.ai's opinion.

⚖️ Peer Comparison — Chemicals & Petrochemicals

Company	MCap (₹ Cr)	P/E	ROCE	ROE	D/E
Solar Industries India Limited	1.57 L Cr	132.3	—	—	—
Pidilite Industries Limited	1.49 L Cr	75.7	—	—	—
SRF Limited	79,723	69.5	—	—	—
Linde India Limited	62,701	141.9	—	—	—
Gujarat Fluorochemicals Limited	40,793	89.6	—	—	—
Navin Fluorine International Limited	35,894	131.5	—	—	—
Himadri Speciality Chemical Limited	30,071	56.6	—	—	—
Deepak Nitrite Limited	24,911	33.3	—	—	—
Atul Limited	20,904	48.8	—	—	—
Tata Chemicals Limited	19,079	-47.1	—	—	—

🔗 Peer Stock Analyses

SOLARINDS PIDILITIND SRF LINDEINDIA FLUOROCHEM

⚠️ Risk Factors

1) Persistent margin pressure from rising input costs, currency volatility, and geopolitical disruptions affecting raw material supply and pricing. 2) Integration risks and execution challenges associated with the Vinpai acquisition and expansion into new segments like natural ingredients. 3) Inconsistent profitability across quarters, with recurring net losses despite revenue growth, raising concerns about sustainable earnings. 4) Execution risk in converting strategic investments into profitable operations without commensurate margin improvement.

📋 Recent Filings

🧠 Analyst's Read

Camlin Fine Sciences is undergoing a strategic pivot toward specialty and natural ingredients, but progress is being offset by macroeconomic headwinds and margin erosion. Investors should monitor margin recovery trends, integration success of recent acquisitions, and any shift toward operational profitability in the next 12-18 months before reconsidering the company's turnaround trajectory.

Based on filing content and financial data. Not a recommendation.

Read the full analysis

Quarterly trends, balance sheet, cash flow, peer comparison, and AI insights — sign up free to unlock.

2 free AI queries per day.

✨ Deep Dive with AI on CAMLINFINE

Data sourced from stock announcements. Analysis generated by StockFin.ai.
For informational purposes only — not investment advice. Updated 2026-07-20.

📡 Get AI alerts when CAMLINFINE files new disclosures

Track CAMLINFINE filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track CAMLINFINE — Free

Free account · 2 AI queries/day